These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 28362152)
1. Finally, Progress in Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction. Fares WH; Kaminski N Am J Respir Cell Mol Biol; 2017 Apr; 56(4):421-422. PubMed ID: 28362152 [No Abstract] [Full Text] [Related]
2. Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives. Guazzi M Circ Heart Fail; 2014 Mar; 7(2):367-77. PubMed ID: 24643889 [No Abstract] [Full Text] [Related]
3. Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction. Sahay S; Khirfan G; Tonelli AR Respir Med; 2017 Oct; 131():94-100. PubMed ID: 28947049 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic importance of pulmonary hypertension in heart failure with preserved ejection fraction]. Carrasco-Sánchez FJ; Ortiz-López E; Galisteo-Almeda L; Camacho-Vázquez C; Ruiz-Frutos C; Pujol-De La Llave E Rev Clin Esp; 2010 Nov; 210(10):489-96. PubMed ID: 20855061 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research. Hoeper MM; Lam CSP; Vachiery JL; Bauersachs J; Gerges C; Lang IM; Bonderman D; Olsson KM; Gibbs JSR; Dorfmuller P; Guazzi M; Galiè N; Manes A; Handoko ML; Vonk-Noordegraaf A; Lankeit M; Konstantinides S; Wachter R; Opitz C; Rosenkranz S Eur Heart J; 2017 Oct; 38(38):2869-2873. PubMed ID: 28011705 [No Abstract] [Full Text] [Related]
6. Development of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction. Farr G; Shah K; Markley R; Abbate A; Salloum FN; Grinnan D Prog Cardiovasc Dis; 2016; 59(1):52-8. PubMed ID: 27350563 [TBL] [Abstract][Full Text] [Related]
7. The role of the pulmonary vasculature in heart failure with preserved ejection fraction. Lewis GD J Am Coll Cardiol; 2009 Mar; 53(13):1127-9. PubMed ID: 19324257 [No Abstract] [Full Text] [Related]
8. Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study. Finch KT; Stratton EA; Farber HW J Heart Lung Transplant; 2016 Nov; 35(11):1370-1373. PubMed ID: 27623099 [No Abstract] [Full Text] [Related]
9. Pulmonary hypertension in heart failure with preserved ejection fraction any pathophysiological role of mitral regurgitation. Guazzi M J Am Coll Cardiol; 2009 Sep; 54(13):1191-2; author reply 1192. PubMed ID: 19761945 [No Abstract] [Full Text] [Related]
11. Pulmonary hypertension in heart failure with preserved ejection fraction: a target for therapy? Waxman AB Circulation; 2011 Jul; 124(2):133-5. PubMed ID: 21747065 [No Abstract] [Full Text] [Related]
12. Combined disease with pulmonary arterial hypertension and pulmonary venous hypertension revealed after treatment of heart failure with preserved ejection fraction in a case with primary Sjögren syndrome. Yamasaki Y; Suzuki K; Kamijima R; Asari Y; Tsuchida K; Mizushima M; Okazaki T; Akashi YJ; Ozaki S; Yamada H Mod Rheumatol; 2018 Jan; 28(1):193-196. PubMed ID: 26052802 [TBL] [Abstract][Full Text] [Related]
13. Management of pulmonary hypertension due to heart failure with preserved ejection fraction. Kanwar M; Tedford RJ; Agarwal R; Clarke MM; Walter C; Sokos G; Murali S; Benza RL Curr Hypertens Rep; 2014 Dec; 16(12):501. PubMed ID: 25320018 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension in heart failure with preserved left ventricular ejection fraction: diagnosis and management. Ohara T; Ohte N; Little WC Curr Opin Cardiol; 2012 May; 27(3):281-7. PubMed ID: 22450719 [TBL] [Abstract][Full Text] [Related]
15. Diffusion Capacity and Mortality in Patients With Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction. Hoeper MM; Meyer K; Rademacher J; Fuge J; Welte T; Olsson KM JACC Heart Fail; 2016 Jun; 4(6):441-9. PubMed ID: 26874383 [TBL] [Abstract][Full Text] [Related]
16. Can Nitrite AMPk Up Sirt-ainty to Treat Heart Failure With Preserved Ejection Fraction? Hsu S; Kass DA Circulation; 2016 Feb; 133(8):692-4. PubMed ID: 26813101 [No Abstract] [Full Text] [Related]
17. Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction. Andersen MJ; Hwang SJ; Kane GC; Melenovsky V; Olson TP; Fetterly K; Borlaug BA Circ Heart Fail; 2015 May; 8(3):542-50. PubMed ID: 25857307 [TBL] [Abstract][Full Text] [Related]
18. The other pulmonary hypertension: heart failure with preserved ejection fraction. Frost AE Int J Clin Pract Suppl; 2011 Aug; (172):3-5. PubMed ID: 21736675 [No Abstract] [Full Text] [Related]
19. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Dixon DD; Trivedi A; Shah SJ Heart Fail Rev; 2016 May; 21(3):285-97. PubMed ID: 26714826 [TBL] [Abstract][Full Text] [Related]
20. SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Lai YC; Tabima DM; Dube JJ; Hughan KS; Vanderpool RR; Goncharov DA; St Croix CM; Garcia-Ocaña A; Goncharova EA; Tofovic SP; Mora AL; Gladwin MT Circulation; 2016 Feb; 133(8):717-31. PubMed ID: 26813102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]